Atypical chemokine receptor 1 deficiency reduces atherogenesis in ApoE-knockout mice

Cardiovascular Research

Volumn 106, Issue 3, 2015, Pages 478-487

  Wan, Wuzhou ^a   Liu, Qian ^a   Lionakis, Michail S ^b   Marino, Ana Paula M P ^a   Anderson, Stasia A ^c   Swamydas, Muthulekha ^b   Murphy, Philip M ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

^c NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

Author keywords

Atherosclerosis; Chemokine receptor; Inflammation; Leukocytes

Indexed keywords

ALPHA CHEMOKINE; APOLIPOPROTEIN E; ATYPICAL CHEMOKINE RECEPTOR 1; BETA CHEMOKINE; CHEMOKINE RECEPTOR; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; VERY LOW DENSITY LIPOPROTEIN; AUTACOID; BLOOD GROUP DUFFY SYSTEM; CCL2 PROTEIN, MOUSE; CELL ADHESION MOLECULE; CELL SURFACE RECEPTOR; CXCL1 CHEMOKINE; CXCL1 PROTEIN, MOUSE; DFY PROTEIN, MOUSE; MONOCYTE CHEMOTACTIC PROTEIN 1;

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; AORTA ROOT; ARTICLE; ATHEROGENESIS; ATHEROSCLEROTIC PLAQUE; ATYPICAL CHEMOKINE RECEPTOR 1 DEFICIENCY; BONE MARROW DERIVED MACROPHAGE; CELL ISOLATION; CELL SUSPENSION; CHOLESTEROL BLOOD LEVEL; COMPARATIVE STUDY; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; LIPID ANALYSIS; MACROPHAGE; MONOCYTE; MONONUCLEAR PHAGOCYTE; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN DEFICIENCY; SMOOTH MUSCLE FIBER; T LYMPHOCYTE; WESTERN DIET; ANIMAL; AORTA; AORTITIS; ATHEROSCLEROSIS; BLOOD GROUP DUFFY SYSTEM; C57BL MOUSE; CELL CULTURE; DEFICIENCY; DISEASE MODEL; GENETICS; IMMUNOLOGY; KNOCKOUT MOUSE; METABOLISM; PATHOLOGY; PHENOTYPE; TIME FACTOR; TRANSPLANTATION;

ADOPTIVE TRANSFER; ANIMALS; AORTA; AORTITIS; APOLIPOPROTEINS E; ATHEROSCLEROSIS; CELL ADHESION MOLECULES; CELLS, CULTURED; CHEMOKINE CCL2; CHEMOKINE CXCL1; DIET, WESTERN; DISEASE MODELS, ANIMAL; DUFFY BLOOD-GROUP SYSTEM; FEMALE; INFLAMMATION MEDIATORS; MACROPHAGES; MICE, INBRED C57BL; MICE, KNOCKOUT; PHENOTYPE; PLAQUE, ATHEROSCLEROTIC; RECEPTORS, CELL SURFACE; T-LYMPHOCYTES; TIME FACTORS;

EID: 84930365688     PISSN: 00086363     EISSN: 17553245     Source Type: Journal    
DOI: 10.1093/cvr/cvv124     Document Type: Article

References (30)

1. Libby P, Lichtman AH, Hansson GK. Immune effector mechanisms implicated in atherosclerosis: from mice to humans. Immunity 2013;38:1092-1104.
2. Galkina E, Ley K. Immune and inflammatory mechanisms of atherosclerosis. Annu Rev Immunol 2009;27:165-197.
3. Koenen RR, Weber C. Chemokines: established and novel targets in atherosclerosis. EMBO Mol Med 2011;3:713-725.
4. WanW, Murphy PM. Regulation of atherogenesis by chemokines and chemokine receptors. Arch Immunol Ther Exp (Warsz) 2013;61:1-14.
5. Bachelerie F, Ben-Baruch A, Burkhardt AM, Combadiere C, Farber JM, Graham GJ, Horuk R, Sparre-Ulrich AH, Locati M, Luster AD, Mantovani A, Matsushima K, Murphy PM, Nibbs R, Nomiyama H, Power CA, Proudfoot AE, Rosenkilde MM, Rot A, Sozzani S, Thelen M, Yoshie O, Zlotnik A. International Union of Pharmacology. LXXXIX. Update on the extended family of chemokine receptors and introducing a new nomenclature for atypical chemokine receptors. Pharmacol Rev 2014;66:1-79.
6. Nibbs R, Graham GJ. Immune regulation by the atypical chemokine receptors. Nat Rev Immunol 2013;13:815-829.
7. Schnabel RB, Baumert J, Barbalic M, Dupuis J, Ellinor PT, Durda P, Dehghan A, Bis JC, Illig T, Morrison AC, Jenny NS, Keaney JF Jr, Gieger C, Tilley C, Yamamoto JF, Khuseyinova N, Heiss G, Doyle M, Blankenberg S, Herder C, Walston JD, Zhu Y, Vasan RS, Klopp N, Boerwinkle E, Larson MG, Psaty BM, Peters A, Ballantyne CM, Witteman JC, Hoogeveen RC, Benjamin EJ, KoenigW, Tracy RP. Duffy antigen receptor for chemokines (Darc) polymorphism regulates circulating concentrations of monocyte chemoattractant protein-1 and other inflammatory mediators. Blood 2010;115: 5289-5299.
8. Voruganti VS, Laston S, Haack K, Mehta NR, Smith CW, Cole SA, Butte NF, Comuzzie AG. Genome-wide association replicates the association of Duffy antigen receptor for chemokines (DARC) polymorphisms with serum monocyte chemoattractant protein-1 (MCP-1) levels in Hispanic children. Cytokine 2012;60: 634-638.
9. Reich D, Nalls MA, Kao WH, Akylbekova EL, Tandon A, Patterson N, Mullikin J, Hsueh WC, Cheng CY, Coresh J, Boerwinkle E, Li M, Waliszewska A, Neubauer J, Li R, Leak TS, Ekunwe L, Files JC, Hardy CL, Zmuda JM, Taylor HA, Ziv E, Harris TB, Wilson JG. Reduced neutrophil count in people of African descent is due to a regulatory variant in the Duffy antigen receptor for chemokines gene. PLoS Genet 2009;5: e1000360.
10. Novitzky-Basso I, Rot A. Duffy antigen receptor for chemokines and its involvement in patterning and control of inflammatory chemokines. Front Immunol 2012; 3:266.
11. Pruenster M, Mudde L, Bombosi P, Dimitrova S, Zsak M, Middleton J, Richmond A, GrahamGJ, Segerer S, Nibbs RJ, Rot A. The Duffy antigen receptor forchemokines transports chemokines and supports their promigratory activity. Nat Immunol 2009;10: 101-108.
12. Zimmerman PA, Ferreira MU, Howes RE, Mercereau-Puijalon O. Red blood cell polymorphism and susceptibility to Plasmodium vivax. Adv Parasitol 2013;81:27-76.
13. Schneider EH, Fowler SC, Lionakis MS, Swamydas M, Holmes G, Diaz V, Munasinghe J, Peiper SC, Gao JL, Murphy PM. Regulation of Motor Function and Behavior by Atypical Chemokine Receptor 1. Behav Genet 2014;44:498-515.
14. Horne K,Woolley IJ. Shedding light on DARC: the role of the Duffy antigen/receptor for chemokines in inflammation, infection and malignancy. Inflamm Res 2009;58: 431-435.
15. Apostolakis S,Chalikias GK, Tziakas DN, Konstantinides S. Erythrocyte Duffy antigen receptor for chemokines (DARC): diagnostic and therapeutic implications in atherosclerotic cardiovascular disease. Acta Pharmacol Sin 2011;32:417-424.
16. Wan W, Lim JK, Lionakis MS, Rivollier A, McDermott DH, Kelsall BL, Farber JM, Murphy PM. Genetic Deletion of Chemokine Receptor Ccr6 Decreases Atherogenesis in ApoE-Deficient Mice. Circ Res 2011;109:374-381.
17. WanW, Lionakis MS, Liu Q, Roffê E, Murphy PM. Genetic deletion of chemokine receptor Ccr7 exacerbates atherogenesis in ApoE-deficient mice. Cardiovasc Res 2013;97: 580-588.
18. Szabo MC, Soo KS, Zlotnik A, Schall TJ. Chemokine class differences in binding to the Duffy antigen-erythrocyte chemokine receptor. J Biol Chem 1995;270: 25348-25351.
19. Kashiwazaki M, Tanaka T, Kanda H, Ebisuno Y, Izawa D, Fukuma N, Akimitsu N, Sekimizu K, Monden M, Miyasaka M. A high endothelial venule-expressing promiscuous chemokine receptorDARCcan bind inflammatory, but not lymphoid, chemokines and is dispensable for lymphocyte homing under physiological conditions. Int Immunol 2003;15: 1219-1227.
20. GuL, Okada Y, Clinton SK, Gerard C, Sukhova GK, Libby P, Rollins BJ. Absence of monocyte chemoattractant protein-1 reduces atherosclerosis in low density lipoprotein receptor-deficient mice. Mol Cell 1998;2:275-2581.
21. Weber C, Meiler S, Döring Y, Koch M, Drechsler M, Megens RT, Rowinska Z, Bidzhekov K, Fecher C, Ribechini E, van Zandvoort MA, Binder CJ, Jelinek I, Hristov M, Boon L, Jung S, Korn T, Lutz MB, Förster I, Zenke M, Hieronymus T, Junt T, Zernecke A. CCL17-expressing dendritic cells drive atherosclerosis by restraining regulatory T cell homeostasis in mice. J Clin Invest 2011;121:2898-2910.
22. BoisvertWA, Santiago R, Curtiss LK, Terkeltaub RA. A leukocyte homologue of the IL-8 receptor CXCR-2 mediates the accumulation of macrophages in atherosclerotic lesions of LDL receptor-deficient mice. J Clin Invest 1998;101:353-363.
23. Dawson TC, Lentsch AB,Wang Z, Cowhig JE, Rot A, Maeda N, Peiper SC. Exaggerated response to endotoxin in mice lacking the Duffy antigen/receptor for chemokines (DARC). Blood 2000;96:1681-1684.
24. Luo H, Chaudhuri A, Zbrzezna V, He Y, Pogo AO. Deletion of the murine Duffy gene (Dfy) reveals that the Duffy receptor is functionally redundant. Mol Cell Biol 2000;20: 3097-3101.
25. Erratum in: Mol Cell Biol 2003;23:3030.
26. Zarbock A, Schmolke M, Bockhorn SG, Scharte M, Buschmann K, Ley K, Singbartl K. The Duffy antigen receptor for chemokines in acute renal failure:Afacilitator of renal chemokine presentation. Crit Care Med 2007;35:2156-2163.
27. Fukuma N, Akimitsu N, HamamotoH, Kusuhara H, Sugiyama Y, Sekimizu K.Arole of the Duffy antigen for the maintenance of plasma chemokine concentrations. Biochem Biophys Res Commun 2003;303:137-139.
28. Lee JS, FrevertCW, Wurfel MM, Peiper SC,Wong VA, Ballman KK, Ruzinski JT, Rhim JS, Martin TR, Goodman RB. Duffy antigen facilitates movement of chemokine across the endothelium in vitro and promotes neutrophil transmigration in vitro and in vivo. J Immunol 2003;170:5244-5251.
29. Khallou-Laschet J, Varthaman A, Fornasa G, Compain C, Gaston AT, Clement M, Dussiot M, Levillain O, Graff-Dubois S, Nicoletti A, Caligiuri G. Macrophage plasticity in experimental atherosclerosis. PLoS One 2010;5:e8852.
30. Loke P, Gallagher I, Nair MG, Zang X, Brombacher F, Mohrs M, Allison JP, Allen JE. Alternative activation is an innate response to injury that requires CD4+ T cells to be sustained during chronic infection. J Immunol 2007;179:3926-3936.